Featured Article
Researchers at Case Western Reserve University say that a class of diabetes drugs used to treat type 2 diabetes may reduce the risk of the development of colorectal cancer (CRC).
Precision Oncology Today
Magazine
Generative AI and Precision Medicine–The Future Is Not What It Used to Be
Generative AI is a new and rapidly emerging form of artificial intelligence that has the potential to revolutionize precision medicine by improving diagnosis, treatment, and drug discovery.
Pushing the Performance of Liquid Biopsies for Cancer with Nanotechnology
Nanotechnology opens the door to a range of unique methods for sensing cancer biomarkers in body fluids, thanks to the unusual properties and capabilities of nanoscale systems. Going small promises big gains in diagnosing and tracking a wide range of tumors.
Trending on Inside Precision Medicine
Seattle Hub for Synthetic Biology Launched with Jay Shendure at the Helm
The newly launched Seattle Hub for Synthetic Biology will build new technologies to record the history of cells over time.
3D Printing Could Build Tissues within Body
A 3D printing technique that uses sound waves could one day be used to build and repair tissues from within the body, paving the way towards minimally invasive medicine.
Class of Diabetes Drugs May Prevent Development of Colorectal Cancer
Researchers at Case Western Reserve University say that a class of diabetes drugs used to treat type 2 diabetes may reduce the risk of the development of colorectal cancer (CRC).
